// App-Quantinova.ai

1540 : Genome-wide association study (GWAS) of response to androgen deprivation therapy (ADT) and survival in metastatic prostate cancer (PCa).

Researchers

Presenter

  • Mark Pomerantz

Principal Investigators

  • Xin Victoria Wang

  • Philip W. Kantoff

  • Wanling Xie

  • Manish Kohli

  • Gwo-Shu Mary Lee

  • Elaine Wang

  • Yu-Hui Chen

  • Noah M. Hahn

  • David Frazier Jarrard

  • Glenn Liu

  • Jorge A. Garcia

  • Michael Anthony Carducci

  • Robert S. DiPaola

  • Matthew L Freedman

  • Christopher Sweeney

Medical Centers

  • Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Mayo Clinic, Rochester, MN

  • The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD

  • University of Wisconsin Hosp and Clinics, Madison, WI

  • University of Wisconsin Comprehensive Cancer Center, Madison, WI

  • Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

  • Rutgers Cancer Institute of New Jersey, New Brunswick, NJ

  • Dana-Farber Cancer Institute, Harvard Cancer Center, Boston, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

  • Prostate cancer

Biomarkers

  • Prostate specific antigen

Drug/Treatment

  • Androgen Tear

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved